Latest filing published 01 Oct 2025 for OCTAVE SPECIALTY GROUP INC, €361k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -32.3%Entry US$11.18 · Close at T+365 US$7.57
- -24.4%Entry US$16.96 · Close at T+365 US$12.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen Michael Ksenak: trading record in brief
This profile gathers the share dealings of Stephen Michael Ksenak in Octave Specialty Group Inc, where the filings describe the role as board member. The record holds 87 filings, for trades running from 1 May 2013 to 29 September 2025.
No open-market sale appears; the market trades are 3 purchases worth €97k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 41 share grants and 41 option exercises.
A typical purchase (the median) is worth €35k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +10.6%. These figures describe past trades and do not predict future prices.
The newest entry dates from 1 October 2025: a share grant of €361k, in Octave Specialty Group Inc. The clock since the last published purchase (8 August 2024) now reads 823 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen Michael Ksenak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,522 shares@ US$9.7219.1% of flowCommon StockSEC:0001628280-25-043472:1
- 129,146 shares0Common StockSEC:0001628280-25-043472:0
- 1,703 shares@ US$8.390.7% of flowCommon StockSEC:0000874501-25-000052:1
- 4,726 shares0Common StockSEC:0000874501-25-000052:0
- 1,967 shares@ US$9.160.9% of flowCommon StockSEC:0000874501-25-000038:1
- 1,967 shares0Common StockSEC:0000874501-25-000038:0
- 582 shares@ US$9.719.2% of flowCommon StockSEC:0000874501-25-000021:1
- 582 sharesCommon StockSEC:0000874501-25-000021:0
- 400 sharesCommon StockSEC:0000874501-25-000021:2
- 400 shares@ US$9.306.0% of flowCommon StockSEC:0000874501-25-000021:3
- 5,000 shares@ US$11.0084.8% of flowCommon StockSEC:0000874501-24-000183:0Canonical exit: 5 Nov 2024 (T+90)
- 218 shares@ US$15.380.2% of flowCommon StockSEC:0000874501-24-000077:1
- 218 shares0Common StockSEC:0000874501-24-000077:0
- 163 shares@ US$16.190.1% of flowCommon StockSEC:0000874501-24-000068:1
- 163 shares0Common StockSEC:0000874501-24-000068:0
- 178 shares@ US$16.940.1% of flowCommon StockSEC:0000874501-24-000051:1
- 178 shares0Common StockSEC:0000874501-24-000051:0
- 1,861 shares@ US$16.251.5% of flowCommon StockSEC:0000874501-24-000020:1
- 1,861 shares0Common StockSEC:0000874501-24-000020:0
- 282 shares@ US$16.410.2% of flowCommon StockSEC:0000874501-23-000062:1
- 282 shares0Common StockSEC:0000874501-23-000062:0
- 178 shares@ US$16.550.1% of flowCommon StockSEC:0000874501-23-000046:1
- 178 shares0Common StockSEC:0000874501-23-000046:0
- 18,606 shares@ US$16.2215.0% of flowCommon StockSEC:0000874501-23-000025:1
- 36,351 shares0Common StockSEC:0000874501-23-000025:0
25 of 82 declarations
